Melissa Ursini, recognized with colorectal most cancers at 37 after misdiagnoses, shared her expertise to focus on the necessity for early screening and...
Brian Sluga is now a testicular most cancers survivor after receiving the analysis when he was 20 years outdated. Compensate for Brian's blogs right...
Innovent dosed the primary affected person in a part 3 trial of IBI354, an anti-HER2 antibody-drug conjugate for platinum-resistant ovarian most cancers.The primary...
